Biotechnology
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment fromchronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

$92.3M

Market Cap • 12/25/2024

2010

(14 years)
Founded

2024

IPO

NASDAQ

Listing Exchange
Flag of US

Burlington

Headquarters • Massachusetts